Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Significant Growth in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Sees Significant Growth in Short Interest
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 398,400 shares, an increase of 52.1% from the August 31st total of 262,000 shares. Based on an average daily trading volume, of 935,600 shares, the days-to-cover ratio is presently 0.4 days.
费森尤斯医疗保健股份公司KGaA(纽约证券交易所代码:fms-GET评级)9月份空头股数业务大幅增长。截至9月15日,空头股数共有39.84万股,比8月31日的26.2万股增加了52.1%。以日均成交量935,600股计算,目前天数与回补比率为0.4天。
Institutional Investors Weigh In On Fresenius Medical Care AG & Co. KGaA
机构投资者看好Fresenius Medical Care AG&Co.KGaA
Several institutional investors and hedge funds have recently made changes to their positions in FMS. Dimensional Fund Advisors LP lifted its stake in shares of Fresenius Medical Care AG & Co. KGaA by 1.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 53,824 shares of the company's stock worth $1,747,000 after buying an additional 516 shares during the period. Invesco Ltd. lifted its position in Fresenius Medical Care AG & Co. KGaA by 54.0% during the fourth quarter. Invesco Ltd. now owns 376,173 shares of the company's stock valued at $12,211,000 after purchasing an additional 131,870 shares during the period. Johnson Financial Group Inc. acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $155,000. Sendero Wealth Management LLC acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $391,000. Finally, Wulff Hansen & CO. acquired a new position in Fresenius Medical Care AG & Co. KGaA during the fourth quarter valued at $351,000. 5.59% of the stock is currently owned by institutional investors and hedge funds.
几家机构投资者和对冲基金最近改变了他们在FMS的头寸。Dimenius Fund Advisors LP在第四季度增持了费森尤斯医疗保健公司(Fresenius Medical Care AG&Co.KGaA)1.0%的股份。Dimension Fund Advisors LP现在拥有53,824股该公司的股票,价值1,747,000美元,在此期间又购买了516股。第四季度,景顺公司将其在Fresenius Medical Care AG&Co.KGaA的持股比例提高了54.0%。景顺股份有限公司目前持有376,173股该公司股票,价值12,211,000美元,在此期间又购买了131,870股。约翰逊金融集团在第四季度收购了费森尤斯医疗保健股份公司的一个新头寸,价值15.5万美元。Sendero Wealth Management LLC在第四季度收购了费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)的一个新头寸,价值39.1万美元。最后是Wulff Hansen&Co.第四季度收购了Fresenius Medical Care AG&Co.KGaA的一个新头寸,价值351,000美元。5.59%的股票目前由机构投资者和对冲基金持有。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
FMS has been the topic of several research reports. Jefferies Financial Group raised shares of Fresenius Medical Care AG & Co. KGaA from an "underperform" rating to a "buy" rating and lifted their price objective for the company from $30.30 to $33.70 in a report on Monday, June 27th. JPMorgan Chase & Co. cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from €51.00 ($52.04) to €23.00 ($23.47) in a report on Monday, August 1st. Truist Financial cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a "hold" rating on the stock in a report on Wednesday, June 22nd. Berenberg Bank cut their price target on shares of Fresenius Medical Care AG & Co. KGaA from €76.70 ($78.27) to €57.95 ($59.13) in a report on Wednesday, August 10th. Finally, UBS Group lowered shares of Fresenius Medical Care AG & Co. KGaA from a "buy" rating to a "neutral" rating in a report on Friday, July 29th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, Fresenius Medical Care AG & Co. KGaA currently has an average rating of "Hold" and an average target price of $45.83.
FMS已经成为几份研究报告的主题。在6月27日星期一的一份报告中,杰富瑞金融集团将费森尤斯医疗保健股份公司的股票评级从表现不佳上调至买入,并将该公司的目标价从30.30美元上调至33.70美元。摩根大通在8月1日周一的一份报告中将费森尤斯医疗保健公司(Fresenius Medical Care AG&Co.KGaA)的目标股价从51.00欧元(合52.04美元)下调至23.00欧元(合23.47美元)。Truist Financial在6月22日周三的一份报告中将Fresenius Medical Care AG&Co.KGaA的股票目标价从34.00美元下调至27.00美元,并将该股的评级设定为持有。贝伦贝格银行在8月10日周三的一份报告中将Fresenius Medical Care AG&Co.KGaA的目标价从76.70欧元(78.27美元)下调至57.95欧元(59.13美元)。最后,瑞银集团在7月29日星期五的一份报告中将Fresenius Medical Care AG&Co.KGaA的股票评级从买入下调至中性。一位股票研究分析师将该股的评级定为卖出,8位分析师给出了持有评级,3位分析师给出了买入评级。根据MarketBeat.com的数据,Fresenius Medical Care AG&Co.KGaA目前的平均评级为持有,平均目标价为45.83美元。
Fresenius Medical Care AG & Co. KGaA Stock Performance
费森尤斯医疗保健股份公司KGaA股票表现
Fresenius Medical Care AG & Co. KGaA (NYSE:FMS – Get Rating) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.41 EPS for the quarter, missing the consensus estimate of $0.45 by ($0.04). Fresenius Medical Care AG & Co. KGaA had a return on equity of 6.70% and a net margin of 4.42%. The company had revenue of $5.07 billion for the quarter, compared to analyst estimates of $4.80 billion. Sell-side analysts predict that Fresenius Medical Care AG & Co. KGaA will post 1.64 EPS for the current year.
Fresenius Medical Care AG&Co.KGaA(纽约证券交易所代码:FMS-GET Rating)最近一次公布季度收益数据是在7月28日星期四。该公司公布本季度每股收益为0.41美元,低于普遍预期的0.45美元(0.04美元)。费森尤斯医疗保健股份公司KGaA的股本回报率为6.70%,净利润率为4.42%。该公司本季度营收为50.7亿美元,而分析师预期为48亿美元。卖方分析师预计,费森尤斯医疗保健股份公司(Fresenius Medical Care AG&Co.KGaA)本年度每股收益将达到1.64股。
About Fresenius Medical Care AG & Co. KGaA
关于费森尤斯医疗保健股份公司
(Get Rating)
(获取评级)
Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Fresenius Medical Care AG&Co KGaA在德国、北美和国际上提供透析护理和相关的透析护理服务。它通过门诊透析诊所网络提供透析治疗以及相关的实验室和诊断服务;材料、培训和患者支持服务,包括临床监测、后续援助和安排将用品运送到患者住所;以及根据合同向美国医院提供为住院的终末期肾病(ESRD)患者和急性肾功能衰竭患者提供的透析服务。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Fresenius Medical Care AG & Co. KGaA (FMS)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Thor Industries Hammers Out A Bottom
- Declining Profits Challenge the CarMax Value Proposition
- 免费获取StockNews.com关于Fresenius Medical Care AG&Co.KGaA(FMS)的研究报告。
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat:回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 雷神工业走出谷底
- 利润下降对CarMax价值主张的挑战
Receive News & Ratings for Fresenius Medical Care AG & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
接受Fresenius Medical Care AG&Co.KGaA Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Fresenius Medical Care AG&Co.KGaA和相关公司的最新新闻和分析师评级的每日简要摘要。